Zobrazeno 1 - 10
of 291
pro vyhledávání: '"W, Fleischhacker"'
Publikováno v:
European Psychiatry, Vol 65, Pp S130-S130 (2022)
Introduction Schizophrenia is a chronic psychiatric illness with periods of remission and relapse. Patients vary in the frequency and severity of relapse, time until relapse and time in remission. Discontinuation of antipsychotic medication is by far
Externí odkaz:
https://doaj.org/article/ce03773cab9f4a59914347512594f9a3
Autor:
Linda Levi, Mor Bar-Haim, Inge Winter-van Rossum, Michael Davidson, Stefan Leucht, Wolfgang W Fleischhacker, Jinyoung Park, John M Davis, Renè S Kahn, Mark Weiser
Publikováno v:
Schizophrenia Bulletin.
Background and Hypothesis This analysis examined the relationship between cannabis use, compliance with antipsychotics and risk for relapse in patients in remission following a first episode of schizophrenia, schizophreniform, or schizoaffective diso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba00302f25432725468b4b112a7303c5
https://doi.org/10.1093/schbul/sbad033
https://doi.org/10.1093/schbul/sbad033
Autor:
Lone Baandrup, Peter Allerup, Mette Ø. Nielsen, Signe W. Düring, Kirsten B. Bojesen, Stefan Leucht, Silvana Galderisi, Armida Mucci, Paola Bucci, Celso Arango, Covadonga M. Díaz‐Caneja, Paola Dazzan, Philip McGuire, Arsime Demjaha, Bjørn H. Ebdrup, Wolfgang W. Fleischhacker, René S. Kahn, Birte Y. Glenthøj
Publikováno v:
Baandrup, L, Allerup, P, Nielsen, M Ø, Düring, S W, Bojesen, K B, Leucht, S, Galderisi, S, Mucci, A, Bucci, P, Arango, C, Díaz-Caneja, C M, Dazzan, P, McGuire, P, Demjaha, A, Ebdrup, B H, Fleischhacker, W W, Kahn, R S & Glenthøj, B Y 2022, ' Scalability of the Positive and Negative Syndrome Scale in first-episode schizophrenia assessed by Rasch models ', Acta Psychiatrica Scandinavica, vol. 146, no. 1, pp. 21-35 . https://doi.org/10.1111/acps.13434
Baandrup, L, Allerup, P, Nielsen, M, Düring, S W, Bojesen, K B, Leucht, S, Galderisi, S, Mucci, A, Bucci, P, Arango, C, Díaz-Caneja, C M, Dazzan, P, McGuire, P, Demjaha, A, Ebdrup, B H, Fleischhacker, W W, Kahn, R S & Glenthøj, B Y 2022, ' Scalability of the Positive and Negative Syndrome Scale in first-episode schizophrenia assessed by Rasch models ', Acta Psychiatrica Scandinavica, vol. 146, no. 1, pp. 21-35 . https://doi.org/10.1111/acps.13434
Baandrup, L, Allerup, P, Nielsen, M, Düring, S W, Bojesen, K B, Leucht, S, Galderisi, S, Mucci, A, Bucci, P, Arango, C, Díaz-Caneja, C M, Dazzan, P, McGuire, P, Demjaha, A, Ebdrup, B H, Fleischhacker, W W, Kahn, R S & Glenthøj, B Y 2022, ' Scalability of the Positive and Negative Syndrome Scale in first-episode schizophrenia assessed by Rasch models ', Acta Psychiatrica Scandinavica, vol. 146, no. 1, pp. 21-35 . https://doi.org/10.1111/acps.13434
Objective: Historically, assessment of the psychometric properties of the Positive and Negative Syndrome Scale (PANSS) has had several foci: (1) calculation of reliability indexes, (2) extraction of subdimensions from the scale, and (3) assessment of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e57d0ba33bedae07bcff68e6b76b9d6
https://curis.ku.dk/ws/files/313158672/Acta_Psychiatr_Scand_2022_Baandrup_Scalability_of_the_Positive_and_Negative_Syndrome_Scale_in_first_u2010episode.pdf
https://curis.ku.dk/ws/files/313158672/Acta_Psychiatr_Scand_2022_Baandrup_Scalability_of_the_Positive_and_Negative_Syndrome_Scale_in_first_u2010episode.pdf
Autor:
René S Kahn, Inge Winter van Rossum, Stefan Leucht, Philip McGuire, Shon W Lewis, Marion Leboyer, Celso Arango, Paola Dazzan, Richard Drake, Stephan Heres, Covadonga M Díaz-Caneja, Dan Rujescu, Mark Weiser, Silvana Galderisi, Birte Glenthøj, Marinus J C Eijkemans, W Wolfgang Fleischhacker, Shitij Kapur, Iris E Sommer, Inge Winter-van Rossum, Metten Somers, Paula C Ywema, Shitisj Kapur, Andreas Meyer-Lindenberg, Wolfgang W Fleischhacker, Anne Lotte Meijering, Jocelyn Petter, Resy Van de Brug, Joost Schotsman, Jildou Zwerver, Jos Peuskens, Marc De Hert, Erik Thys, Lucho G Hranov, Valentin Hranov, Jan Libiger, Richard Köhler, Pavel Mohr, Birte Glenthoj, Brian Broberg, Signe Düring, Lone Baandrup, Stephane Jamain, Ina Giegling, Mor Bar Heim, Michael Davidson, Paola Bucci, Armida Mucci, Janusz Rybakowski, Agnieszka Remlinger-Molenda, Ilan Gonen, Paull Radu, Marina Díaz-Marsá, Alberto Rodriguez, Tomas Palomo, Roberto Rodriguez-Jimenez, Paz García-Portilla, Miquel Bernardo, Julio Bobes, Christina Vilares Oliveira, Gregor Berger, Claudia Wildt, Roccio Perez-Iglesias, Sarah Gregory, Danielle Wilson
Publikováno v:
The Lancet Psychiatry, 5(10), 797. Elsevier Limited
McGuire, P & Dazzan, P 2018, ' Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE) : a three-phase switching study ', The lancet. Psychiatry, vol. 5, no. 10, pp. 797-807 . https://doi.org/10.1016/S2215-0366(18)30252-9
The Lancet. Psychiatry, 5(10), 797-807. ELSEVIER SCI LTD
McGuire, P & Dazzan, P 2018, ' Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE) : a three-phase switching study ', The lancet. Psychiatry, vol. 5, no. 10, pp. 797-807 . https://doi.org/10.1016/S2215-0366(18)30252-9
The Lancet. Psychiatry, 5(10), 797-807. ELSEVIER SCI LTD
BACKGROUND: No established treatment algorithm exists for patients with schizophrenia. Whether switching antipsychotics or early use of clozapine improves outcome in (first-episode) schizophrenia is unknown.METHODS: This three-phase study was done in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be5a2a19dd5e39afa4153416617ec0a0
https://doi.org/10.1016/S2215-0366(18)30252-9
https://doi.org/10.1016/S2215-0366(18)30252-9
Placebo effects in adult and adolescent patients with schizophrenia: combined analysis of nine RCT s
Autor:
Masaru Mimura, T. Suzuki, K. Kubo, Hiroyuki Uchida, W. W. Fleischhacker, Norio Yasui-Furukori
Publikováno v:
Acta Psychiatrica Scandinavica. 139:108-116
Objective To examine characteristics of placebo responders and seek optimal criteria of early improvement with placebo for predicting subsequent placebo response in patients with schizophrenia. Method Data of 672 patients with schizophrenia randomize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::817ac0244333ab0ee79f64c418030ebd
https://doi.org/10.1111/acps.12960
https://doi.org/10.1111/acps.12960
Autor:
Michaela Defrancesco, Josef Marksteiner, W. W. Fleischhacker, Imrich Blasko, Eberhard A. Deisenhammer, Georg Kemmler
Publikováno v:
Journal of Alzheimer's Disease. 59:1439-1448
Background Mild cognitive impairment (MCI) has been suggested to represent a prodromal stage of dementia and to confer a high risk for conversion to dementia Alzheimer's type (DAT). Objectives In this study, we examined the predictive value of depres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cb2e8413b54dad6d9d204bdfee7237d
https://doi.org/10.3233/jad-161135
https://doi.org/10.3233/jad-161135
Autor:
Fabienne Wartelsteiner, Anna-Sophia Welte, Georg Kemmler, W. W. Fleischhacker, Beatrice Frajo-Apor, Alex Hofer, Yohsuke Mizuno, Silvia Pardeller, Hiroyuki Uchida, Catherine Sondermann
Publikováno v:
Acta Psychiatrica Scandinavica. 134:360-367
Objective Improving quality of life (QoL) is an important objective in the treatment of schizophrenia. The aim of the current study was to examine to what extent resilience, self-esteem, hopelessness, and psychopathology are correlated with QoL. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99f291d4c86c131f43fc33e5620e24c9
https://doi.org/10.1111/acps.12628
https://doi.org/10.1111/acps.12628
Autor:
Dazzan, P (Dazzan, Paola)( 1 ), Reinders, AATS (Reinders, A. A. T. Simone)( 1 ), Shatzi, V (Shatzi, Vasiliki)( 2 ), Carletti, F (Carletti, Francesco)( 1 ), Arango, C (Arango, Celso)( 3 ), Fleischhacker, W (Fleischhacker, Wolfgang)( 4 ), Galderisi, S (Galderisi, Silvana)( 5 ), Mucci, A (Mucci, Armida)( 5 ), Glenthoj, B (Glenthoj, Birte)( 6 ), Egerton, A (Egerton, Alice)( 2 ), Barker, G (Barker, Gareth)( 2 ), Leucht, S (Leucht, Stefan)( 7 ), Meyer-Lindenberg, A (Meyer-Lindenberg, Andreas)( 8 ), Kahn, RS (Kahn, Rene S. )( 9 ), Rujescu, D (Rujescu, Dan)( 10 ), Sommer, I (Sommer, Iris)( 11 ), Winter, I (Winter, Inge)( 9 ), McGuire, P (McGuire, Philip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3977::32ef5d717ef968f0fdcabea3a255d203
http://hdl.handle.net/11591/394407
http://hdl.handle.net/11591/394407
Autor:
W. W. Fleischhacker, Silvia Pardeller, Masaru Mimura, Georg Kemmler, Beatrice Frajo-Apor, Fabienne Wartelsteiner, Yuya Mizuno, Alex Hofer, T. Suzuki, Hiroyuki Uchida
Publikováno v:
Mizuno, Y, Hofer, A, Frajo-Apor, B, Wartelsteiner, F, Kemmler, G, Pardeller, S, Suzuki, T, Mimura, M, Fleischhacker, W W & Uchida, H 2017, ' Religiosity and psychological resilience in patients with schizophrenia and bipolar disorder: an international cross-sectional study ', Acta Psychiatrica Scandinavica . https://doi.org/10.1111/acps.12838
Objective The impact of religious/spiritual activities on clinical outcomes in patients with serious mental illnesses remains controversial, which was addressed in this international cross-sectional study. Method Three-hundred sixty-nine subjects wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a79487ca3a8ec8f90b74bc15050e982
https://kclpure.kcl.ac.uk/ws/files/82725866/Religiosity_and_Psychological_Resilience_MIZUNO_Firstonline15November2017_GREEN_AAM.pdf
https://kclpure.kcl.ac.uk/ws/files/82725866/Religiosity_and_Psychological_Resilience_MIZUNO_Firstonline15November2017_GREEN_AAM.pdf
Autor:
Susanne Baumgartner, W. W. Fleischhacker, Julia Engl, Christoph Ebenbichler, Georg Kemmler, Peter Malik, Alexander Tschoner, Susanne Kaser, Monika Edlinger, Maria A. Rettenbacher, Alex Hofer
Publikováno v:
Journal of Clinical Psychopharmacology. 30:711-715
Objective Patients with schizophrenia often experience sexual dysfunction (SD), to which disorder-related factors like negative symptoms and nondisorder-related factors can theoretically contribute. Thus, we investigated the correlation of SD and ser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b70eea41d976c3f90326660b6abf548
https://doi.org/10.1097/jcp.0b013e3181faf0e3
https://doi.org/10.1097/jcp.0b013e3181faf0e3